MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNK
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This is an open label multicentre trial, evaluating the utility of MRI-guided thrombolysis
for stroke beyond time window by Tenecteplase (TNK-tPA). This exploratory study was to
describe the feasibility and outcome of thrombolytic therapy with TNK-tPA in 4.5-24 hours
after stroke guided by a mismatch between diffusion-weighted imaging and FLAIR in the region
of ischemia.